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Background: Postpartum hemorrhage (PPH) is a leading cause of obstetric morbidity. There is limited
understanding of patients’ knowledge about blood loss at delivery, PPH, and PPH-related morbidities,
including transfusion and anemia.
Methods: We surveyed 100 healthy postpartum patients who underwent vaginal or cesarean delivery
about blood loss, and whether they received information about transfusion and peripartum hemoglobin
(Hb) testing. Responses were compared between women undergoing vaginal delivery vs. cesarean
delivery; P<0.05 considered as statistically significant.
Results: In our cohort, 49 women underwent vaginal delivery and 51 women underwent cesarean
delivery. Only 29 (29%) of women provided blood loss estimates for their delivery. Women who
underwent cesarean delivery were more likely to receive clear information about transfusion therapy
than those undergoing vaginal delivery (43.1% vs. 20.4% respectively; P=0.04). Women who underwent
vaginal delivery were more likely to receive results of postpartum Hb tests compared to those
undergoing cesarean delivery (49% vs. 29.4%; P=0.02).
Conclusion: Our findings suggest that women are poorly informed about the magnitude of blood loss at
delivery. Hematologic information given to patients varies according to mode of delivery. Further
research is needed to better understand the clinical implications of patients’ knowledge gaps about PPH,
transfusion and postpartum anemia.
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48 Abstract: 49 Background: Postpartum hemorrhage (PPH) is a leading cause of obstetric morbidity.  There is 50 limited understanding of patients’ knowledge about blood loss at delivery, PPH, and PPH-related 51 morbidities, including transfusion and anemia. 52 Methods: We surveyed 100 healthy postpartum patients who underwent vaginal or cesarean 53 delivery about blood loss, and whether they received information about transfusion and 54 peripartum hemoglobin (Hb) testing. Responses were compared between women undergoing 55 vaginal delivery vs. cesarean delivery; P<0.05 considered as statistically significant. 56 Results: In our cohort, 49 women underwent vaginal delivery and 51 women underwent 57 cesarean delivery. Only 29 (29%) of women provided blood loss estimates for their delivery. 58 Women who underwent cesarean delivery were more likely to receive clear information about 59 transfusion therapy than those undergoing vaginal delivery (43.1% vs. 20.4% respectively; 60 P=0.04). Women who underwent vaginal delivery were more likely to receive results of 61 postpartum Hb tests compared to those undergoing cesarean delivery (49% vs. 29.4%; P=0.02). 62 Conclusion: Our findings suggest that women are poorly informed about the magnitude of blood 63 loss at delivery. Hematologic information given to patients varies according to mode of delivery. 64 Further research is needed to better understand the clinical implications of patients’ knowledge 65 gaps about PPH, transfusion and postpartum anemia.6667 Key Words: 68 postpartum hemorrhage; anemia; patient knowledge; estimated blood loss69 Short title: Patient survey of blood loss at delivery
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71 Introduction:72 In the United States, the rate of severe postpartum hemorrhage (PPH) has been steadily 73 increasing.1,2 In order to decrease the frequency of PPH, clinical guidelines have been published 74 to optimize PPH management practices.3-5 Obstetric and anesthetic care providers may also 75 obtain updates about PPH management from literature review and other educational forums, 76 such as seminars and conferences. However, it is uncertain whether patients receive information 77 about PPH and PPH-related morbidities, such as transfusion and postpartum anemia.78 If patients are inadequately informed about PPH, transfusion, and postpartum anemia, 79 this may have important clinical and health-related implications. Firstly, PPH is recognized as an 80 important cause of postpartum anemia. Women who develop postpartum anemia may be at risk 81 for anemia-related morbidities, including: postpartum depression, reduced cognition, and 82 impaired maternal-neonatal bonding.6 Secondly, patients who experience PPH may not receive 83 postpartum counseling. This may negatively impact on how patients cope with the emotional 84 trauma of experiencing major PPH.7 Thirdly, patient-centered care and shared decision-making 85 about transfusion have been promoted in the perioperative and medical literature.8-10 These 86 approaches have not been well described in the obstetric setting, therefore examining patients’ 87 knowledge of anticipated and actual blood loss at delivery may help inform clinical practice. 88 To evaluate patients’ knowledge and perceptions of postpartum blood loss, we surveyed a 89 cohort of women who underwent vaginal delivery or cesarean delivery at a US tertiary obstetric 90 center. We secondarily examined whether patients receive information from their care providers 91 about transfusion, and antepartum and postpartum Hb levels. 9293
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94 Methods:95 This study was approved by Stanford University IRB, Stanford, CA (Protocol#26391). 96 Using a convenience sample, we enrolled 100 healthy (ASA physical status 1 or 2) patients who 97 underwent vaginal delivery or cesarean delivery at Lucile Packard Children’s Hospital, a tertiary 98 obstetric center in California, USA. During the postpartum hospitalization, postpartum patients 99 were approached and written informed consent was obtained. We excluded women with 100 psychological disorders or psychiatric disease. 101  For this study, we asked patients two sets of questions about blood loss. One set of 102 questions assessed patients’ baseline knowledge of normal blood loss following an 103 uncomplicated vaginal or cesarean delivery. The second set of questions was related to the blood 104 loss that occurred for their actual delivery (vaginal or cesarean). For each set of questions, a 105 trained study investigator (PH, BR, KA) surveyed patients using a written questionnaire and 106 recorded patients’ responses. Survey questions are presented in an online supplement 107 (Supplement 1). The questionnaire also contained questions related to patients’ socioeconomic 108 status and educational background. 109 For the first set of questions, we asked patients to quantify volumes of blood loss for a 110 normal, uncomplicated vaginal delivery and cesarean delivery. For the second set of questions, 111 we asked patients to quantify the estimated blood loss for their actual delivery (hereafter referred 112 to as EBLpatient), and to indicate whether an obstetric care provider informed them of their EBL. 113 For each patient’s delivery hospitalization, we abstracted demographic, medical, obstetric and 114 laboratory data from the electronic medical record, including: total EBL for their delivery 115 (hereafter referred to as EBLdelivery), the antenatal hemoglobin (Hb) level most proximate to 
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116 delivery, the postpartum Hb level measured closest to the day of hospital discharge, and relevant 117 transfusion data. 118 For our secondary analysis, we asked directed questions related to transfusion and Hb 119 testing. We assessed whether patients were given information, during the antenatal period, about 120 transfusion, and whether they would consent to a transfusion, if clinically indicated. We asked 121 patients whether they received information about their antenatal and postpartum Hb levels from 122 obstetric care providers. 123 Statistical Analyses:124 Data are presented as mean (standard deviation), median [interquartile range], and number 125 (percentages), as appropriate. For continuous data, we assessed normal distributions using QQ 126 plots and the Kolmogorov-Smirnov test. We compared patient characteristics and survey 127 responses between women who underwent vaginal vs. cesarean delivery with a t test or Mann-128 Whitney test for continuous data, and χ2 test or Fisher’s exact test for categorical data. We 129 compared EBLpatient values to EBLdelivery values for women who underwent vaginal and cesarean 130 delivery respectively, using Wilcoxon signed rank sum test. 131 Using EBL data, we classified PPH using the following EBL thresholds: ≥ 500 ml EBL 132 for vaginal delivery and ≥1000 ml EBL for cesarean delivery. We calculated sensitivity, 133 specificity, positive predictive value (PPV) and negative predictive value (NPV) to determine 134 whether PPH was accurately classified by patients’ EBL estimates for their actual delivery. 135 Statistical analysis was performed using STATA version 12 (Stata Corp., College Station, TX). 136 P<0.05 was considered as statistically significant.137138 Results: 
PeerJ reviewing PDF | (2016:06:11098:1:0:NEW 20 Jul 2016)
Manuscript to be reviewed
139 A total of 100 patients were recruited, of which 49 underwent vaginal delivery and 51 underwent 140 cesarean delivery. Demographic, socioeconomic, and obstetric characteristics for the full cohort 141 and for women stratified by mode of delivery are presented in Table 1. In the full cohort, the 142 majority of women had private health insurance, were Caucasian or Asian, married, and had an 143 annual household income of at least $50,000. Compared to women who underwent vaginal 144 delivery, women who underwent cesarean delivery were older, had a higher parity, were 145 delivered at a later gestational age, and were more likely to have undergone prior cesarean 146 delivery.147 Data related to the first set of questions about blood loss for an uncomplicated vaginal or 148 cesarean delivery are presented in Table 2. Over two-thirds of patients did not provide estimates 149 for normal blood loss after an uncomplicated vaginal or cesarean delivery. Among those who 150 were willing to provide estimates, patients reported that the mean normal blood loss is higher 151 after an uncomplicated cesarean delivery compared with an uncomplicated vaginal delivery. 152 The median [IQR] EBLdelivery values were significantly higher for women who underwent 153 cesarean delivery compared to vaginal delivery (730 [600-1000] ml vs. 250 [200-300] ml 154 respectively; P<0.001). A total of 18 women experienced PPH: four of these women underwent 155 vaginal delivery, and 14 underwent cesarean delivery. Of note, no patients received transfusion. 156 Complete data on EBLpatient and EBLdelivery values were available for only 29 patients 157 (Figure 1). For those with complete data who underwent vaginal delivery (n=16), EBLpatient 158 values were significantly higher than EBLdelivery values (400 ml [300-578 ml] vs. 250 [200-300 159 ml] respectively; P=0.02). In contrast, for those with complete data who underwent cesarean 160 delivery (n=13), EBLpatient values were significantly lower than EBLdelivery values (550 ml [400-161 800 ml] vs. 750 [600-1000 ml]; P=0.02). For the 29 patients with complete EBLpatient  and 
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162 EBLdelivery data, we calculated sensitivity, specificity, PPV and NPV to determine whether PPH 163 was accurately classified according to EBLpatient values. The sensitivity was 60% (95% 164 CI=14.7% - 94.7%), specificity was 83.3% (95% CI=62.6%-95.3%), PPV was 42.9% (95% 165 CI=9.9%-81.6%), and NPV was 90.9% (95% CI=70.8%-98.9%). 166 Hb levels were not measured before or after delivery for 11 women and 20 women, 167 respectively. Predelivery Hb levels were similar for those who underwent vaginal vs. cesarean 168 delivery: 12.4 (1.4) g/dl vs. 12.3 (0.9) g/dl, respectively; P=0.8. Similarly, no significant 169 difference was observed in the last Hb measured before hospital discharge between women who 170 underwent vaginal vs. cesarean delivery: 10.6 (1.1) g/dl vs. 10.4 (1.0) g/dl, respectively; P=0.3. 171 Data of patients’ knowledge of transfusion and Hb levels are presented in Table 3. 172 Women who underwent cesarean delivery were more likely to have received clear and 173 understandable information about transfusion and were more likely to consent to transfusion 174 compared to women who had a vaginal delivery. With regard to Hb levels, patients who 175 underwent vaginal delivery were more likely to have known their Hb level before delivery 176 compared to those who underwent cesarean delivery. The proportion of patients who stated that 177 their postpartum Hb level was measured was similar among women who underwent vaginal vs 178 cesarean delivery (40.8% vs. 47% respectively; P=0.74). However, among women who stated 179 that their postpartum Hb level was measured, only 3 (7%) were given the test result. 180181 Discussion:182 Our study provides insight into obstetric patients’ perceptions and knowledge of blood loss at 183 delivery, transfusion, and laboratory testing for anemia. Over two-thirds of patients did not 184 provide blood loss estimates for their delivery. Additionally, less than 50% of patients indicated 
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185 that they received information about their pre- or post-delivery Hb levels. Lastly, the quality of 186 transmitted information about transfusion and patients’ consent for transfusion varied according 187 to mode of delivery. Based on our findings, a low proportion of women who deliver at a US 188 tertiary obstetric center receive information about the clinical implications of peripartum blood 189 loss, transfusion, and Hb testing before and after delivery.190 It is unclear why the majority of women in our study did not provide blood loss 191 (EBLpatient) values. We speculate that the reason is that many patients did not receive blood loss 192 information after delivery. Those who did provide blood loss estimates for their delivery were 193 relatively poor at correctly classifying PPH (sensitivity=60%; PPV=42.9%). One possible 194 explanation for these findings is that, within this subcohort [of women who gave blood loss 195 estimates], women may not have been informed about the magnitude of their peripartum blood 196 loss. In addition, it is also possible that some women correctly estimated their blood loss without 197 receiving any EBL information from their obstetric care provider. 198 Although it is unclear whether patients who undergo uncomplicated deliveries need to be 199 notified of their EBL or postpartum Hb levels, patients who experience PPH may benefit from 200 receiving more detailed information about these indices. Thompson et al. reported that patients 201 who experience PPH express interest in receiving information related to their delivery, and may 202 benefit from counseling, psychological support, and assistance with physical recovery.11 203 Furthermore, physicians’ estimate of blood loss can often be lower than the actual volume of 204 blood lost at delivery.12,13 Therefore, if blood loss is underestimated for women with PPH, then 205 these women may develop anemia that goes undetected after delivery. To improve patient 206 awareness of postpartum anemia, there may be benefit in providing patients with information 
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207 sheets which contain advice about seeking medical review if they experience anemia-related 208 symptoms (e.g., low mood, fatigue, poor cognition). 209 In our study, patients who underwent cesarean delivery were more likely to receive 210 information about transfusion compared to those who underwent vaginal delivery. Obstetricians 211 may be more likely to discuss the need for transfusion with patients who undergo cesarean 212 delivery, as these women are at greater risk of PPH than those undergoing vaginal delivery.14 213 Surprisingly, 20% of women who underwent vaginal delivery reported that they would not 214 provide consent for a blood transfusion should the obstetrician deem it necessary. This finding is 215 somewhat concerning as prompt transfusion therapy may be needed for women who experience 216 severe PPH or postpartum anemia. Misconceptions about transfusion risk may explain why 217 patients object to transfusion therapy. These misconceptions may be influenced by 218 sociodemographic factors. For example, in a survey of patients’ perceptions of transfusion by 219 Vetter et al., patients with a high school education or less expressed increased concern about the 220 risk of allergic reaction, dyspnea, human immunodeficiency virus transmission, and medical 221 error.9 In a different survey examining patients’ beliefs about transfusion, Finucane et al. 222 observed that patients’ decision to receive transfusion may vary according to patient’s sex, 223 race/ethnicity, and prior educational history.15  In light of these findings, counseling during the 224 antenatal period may help allay the concerns and fears of patients who express a desire to avoid 225 transfusion. 226 Antenatal and postpartum anemia can affect up to 52% and 24% women respectively.6,16 227 However, in our study, despite the majority of women having Hb levels measured before and 228 after delivery, fewer than 50% indicated that they received any information regarding the results 229 of these tests. Hb testing was less common for women who underwent vaginal delivery. To 
PeerJ reviewing PDF | (2016:06:11098:1:0:NEW 20 Jul 2016)
Manuscript to be reviewed
230 determine optimal screening practices, more population-based studies are needed to assess the 231 frequency of postpartum anemia. 232 There are some limitations to our study. Our cohort size was relatively small, with 233 patients recruited at a single, tertiary obstetric center. In addition, the majority of women had 234 private insurance, were well educated, were Caucasian or Asian, and had an annual income of > 235 $50,000. Therefore, the specific characteristics of our study population limit the generalizability 236 of our findings. Further investigations are needed to assess knowledge and perceptions of blood 237 loss among women from other sociodemographic backgrounds, including those without English 238 proficiency. Our study cohort comprised healthy women who underwent uncomplicated vaginal 239 or cesarean delivery. We did not collect information on indications for cesarean delivery or, if 240 given, the timing of antenatal counseling. It is possible that the presence of select risk factors for 241 PPH may influence if and when physicians inform patients about peripartum blood loss, anemia 242 or transfusion. For example, the likelihood of antenatal counseling may be greater for women 243 with antenatal conditions linked to severe PPH, such as placenta previa or accreta, than for 244 women with uncomplicated pregnancies. Recall bias is a possibility as we performed our survey 245 after delivery. Patients’ responses may have differed if our survey had been prospectively 246 performed. Lastly, this was a convenience sample, therefore the proportion of patients who 247 underwent cesarean delivery in our study cohort (51%) is not representative of the rate of 248 cesarean delivery at LPCH (approximately 31%). In addition, in our study cohort, the proportion 249 of women who experienced PPH (18%) is higher than reported in the literature.12 As our study 250 was exploratory in nature, further studies are needed to validate our findings using populations 251 are more representative of a typical delivery population.
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252 In conclusion, our findings suggest that obstetric patients receive limited information 253 about peripartum blood loss, transfusion and peripartum Hb testing. In addition, patients’ 254 understanding of transfusion and postpartum Hb testing may vary according to mode of delivery. 255 Future qualitative studies are needed to examine whether better patient-provider communication 256 improves patients’ understanding and awareness about the clinical implications of PPH, anemia, 257 and transfusion therapy, and to examine alternative ways to disseminate relevant information to 258 patients.  259260 Acknowledgements: The authors would like to thank Flavya Esteves who assisted with data 261 collection for this study.262
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305306 Figure 1. Recorded estimated blood loss versus patients’ estimate for blood loss at delivery. 307 Blood loss was not recorded in the medical records of 4 patients who underwent vaginal 308 delivery and 1 patient who underwent cesarean delivery. 309 32 patients for vaginal delivery and 37 patients for cesarean delivery did not know or chose 310 not to answer this question. 311312313314315 Table 1. Maternal Characteristics
All Deliveries 
(n=100)
Vaginal 
Deliveries 
(n=49)
Cesarean 
Deliveries 
(n=51)
P value
Maternal age (y) 33 (6) 30 (5) 36 (6) <0.001
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Race / Ethnicity: 0.54
Caucasian 51 (51.0%) 27 (55.1%) 24 (47.1%)
Asian 32 (32.0%) 14 (28.6%) 18 (35.3%)
African-  
American
2 (2.0%) 0 (0.0%) 2 (3.9%)
Other 15 (15.0%) 8 (16.3%) 7 (13.7%)
Insurance type: 0.08
Private 81 (81.0%) 36 (73.5%) 45 (88.2%)
Public 19 (19.0%) 13 (26.5%) 6 (11.8%)
Parity 1 [0-1] 0 [0-1] 1 [0-1] 0.03
Highest level of 
education:
0.61
Less than 
college
23 (23.0%) 13 (26.5%) 10 (19.6%)
College degree 26 (26.0%) 11 (22.4%) 15 (29.4%)
Graduate 
degree
51 (51.0%) 25 (51.0%) 26 (51.0%)
Annual 
household 
income:
0.45
Less than 
$10,000
2 (2.0%) 2 (4.1%) 0 (0.0%)
Between 
$10,000 - 
$49,000
19 (19.0%) 10 (20.4%) 9 (17.6%)
Equal to or 
greater than 
$50,000
75 (75.0%) 35 (71.4%) 40 (78.4%)
Missing 4 (4.0%) 2 (4.1%) 2 (3.9%)
Marital status: 1.00
Married 91 (91.0%) 45 (91.8%) 46 (90.2%)
Unmarried – 
lives with other 
adults
7 (7.0%) 3 (6.1%) 4 (7.8%)
Unmarried – 
lives without 
1 (1.0%) 0 (0.0%) 1 (2.0%)
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other adults
Unknown 1 (1.0%) 1 (2.0%) 0 (0.0%)
Gestational age 
at delivery 
(weeks)
39 [38-39] 39 [38-40] 39 [37-39] 0.02
Prior cesarean 
delivery
30 (30.0%) 2 (4.1%)a 28 (54.9%) <0.001
Multiple 
gestation:
1.00
    Singleton 97 (97.0%) 48 (98.0%) 49 (96.1%)
Twins or 
higher-order
3 (3.0%) 1 (2.0%) 2 (3.9%)
Known history of 
anemia or 
coagulation 
disorder
6 (6.0%) 4 (8.2%) 2 (3.9%) 0.43
316 Data presented as mean (SD), median [IQR], and n (%).317 a Missing data for 1 patient318319
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321 Table 2. Survey of Patients’ Knowledge of Normal Blood Loss for an Uncomplicated 322 Vaginal and Cesarean Delivery323
All Deliveries 
(n=100)
Vaginal 
Deliveries 
(n=49)
Cesarean 
Deliveries 
(n=51)
P value
What is the 
normal blood 
loss after a 
vaginal delivery? 
350 [350-500]a 350 [350-500] 350 [350-500] 0.70
What is the 
normal blood 
loss after a CD?
750 [500-750]b 750 [350-750] 750 [500-750] 0.66
324 Data presented as median [interquartile range] and n (%)325 CD = cesarean delivery; EBL = estimated blood loss.326 a 39 patients for vaginal delivery and 34 patients for cesarean delivery did not know or chose not to 327 answer this question.328 b 44 patients for vaginal delivery and 32 patients for cesarean delivery did not know or chose not to 329 answer this question.330331
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332 Table 3. Survey of Patients’ Knowledge of Transfusion and Hemoglobin Values333
All Deliveries 
(n=100)
Vaginal 
Deliveries 
(n=49)
Cesarean 
Deliveries (n=51)
P value
What was the 
quality of 
information you 
received about 
blood transfusion?
0.04
    Clear and     
    understandable
32 (32.0%) 10 (20.4%) 22 (43.1%)
    Incompletely 
    explained but I  
    have a good 
    understanding
41 (41.0%) 20 (40.8%) 21 (41.2%)
    Poorly  
    explained and I 
    have limited 
    understanding
10 (10.0%) 6 (12.2%) 4 (7.8%)
    Not explained 
    and I have no 
    understanding
13 (13.0%) 10 (20.4%) 3 (5.9%)
    Missing 4 (4.0%) 3 (6.1%) 1 (2.0%)
If a blood 
transfusion was 
needed, would 
you give consent?
0.09
    Yes 85 (85.0%) 38 (77.6%) 47 (92.2%)
    No 14 (14.0%) 10 (20.4%) 4 (7.8%)
    Missing 1 (1.0%) 1 (2.0%) 0 
Were you given 
any information 
about your Hb 
level before your 
delivery?
0.02
    Yes 39 (39.0%) 24 (49.0%) 15 (29.4%)
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    No 57 (57.0%) 25 (51.0%) 32 (62.8%)
    Missing 4 (4.0%) 0 (0.0%) 4 (7.8%)
Was your Hb level 
measured after 
delivery?
0.74
    Yes 44 (44.0%) 20 (40.8%) 24 (47.0%)
    No 33 (33.0%) 18 (36.7%) 15 (29.4%)
    Don’t know 22 (22.0%) 11 (22.4%) 11 (21.6%)
    Missing 1 (1.0%) 0 1 (2.0%)334 Data presented as n (%)335 Hb = hemoglobin.336337
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